|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 5 Tissue Microarray - LS-SCA5This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA5 |
| Product Name: | General Cancer Screen 5 |
| Description: | Normal and cancer specimens with stage/grade and clinical data, from 21 human tissue types: Adrenal, Adipose, Bladder, Brain, Breast, Colon, Duodenum, Esophagus, Fallopian Tube, Gall Bladder, Kidney, Liver, Lung, Lymphoma, Ovary, Pancreas, Parotid, Prostate, Rectum, Skin, Small Intestine |
| Format: | FFPE |
| Category: | Human Multi-Tumor and Normal |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 4-6 µm |
| Cases: | 95 |
| Cores: | 95 |
| Slides Per Set: | 1 |
LS-SCA5 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Adipose (Adi); Adrenal gland (Adr); Bladder (Bla); Brain (Brn); Breast (Bst); Colon (Col); Esophagus (Eso); Fallopian tube (Fal); Gallbladder (Gal); Kidney (Kid); Liver (Liv); Lung (Lng); Lymph node (Lym); Ovary (Ova); Pancreas (Pnc); Parotid gland (Pdg); Placenta (Pla); Prostate (Pst); Rectum (Rec); Skeletal muscle (Skl); Skin (Skn); Small intestine (SmI); Small intestine, Duodenum (SmI); Soft tissue (Sft); Stomach (Sto); Testis (Tes); Throat, Pharynx (Thr); Thymus (Tms); Thyroid (Tyd); Tonsil (Tsl); Uterus (Ute);
LS-SCA5 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Differentiation | Tumor History | Tumor Size |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | F | 29 y | Placenta (Pla) | Normal | Benign non-neoplastic | ||||
| 1 | A3 | Human | M | 47 y | Adrenal gland (Adr) | Pheochromocytoma | Tumor | T2N0M0 | Moderately | 1 Month | 6x6 cm |
| 1 | A4 | Human | M | 22 y | Adrenal gland (Adr) | Normal | Benign non-neoplastic | ||||
| 1 | A5 | Human | F | 57 y | Adipose (Adi) | Liposarcoma | Malignant | T3N0M0 | Moderately | 2 Months | 28x18x6 cm |
| 1 | A6 | Human | M | 26 y | Adipose (Adi) | Normal | Benign non-neoplastic | ||||
| 1 | A7 | Human | M | 36 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | Moderately | 1 Year | 10x7x5 cm |
| 1 | A8 | Human | M | 29 y | Bladder (Bla) | Normal | Benign non-neoplastic | ||||
| 1 | A9 | Human | M | 68 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | Moderately | 3 Days | 2x1x0.5 cm |
| 1 | A10 | Human | M | 34 y | Bladder (Bla) | Normal | Benign non-neoplastic | ||||
| 1 | A11 | Human | F | 34 y | Brain (Brn) | Meningioma | Tumor | T2N0M0 | 2 Months | 6x5x5 cm | |
| 1 | A12 | Human | M | 73 y | Brain (Brn) | Normal | Benign non-neoplastic | ||||
| 1 | B1 | Human | F | 82 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T3N1M0 | Moderately | 4 Years | 5x6 cm |
| 1 | B2 | Human | F | 27 y | Breast (Bst) | Normal | Benign non-neoplastic | ||||
| 1 | B3 | Human | F | 26 y | Breast (Bst) | Fibroadenoma | Tumor | T1N0M0 | 2 Months | 1.8x1.5x0.7 cm | |
| 1 | B4 | Human | F | 44 y | Breast (Bst) | Normal | Benign non-neoplastic | ||||
| 1 | B5 | Human | F | 65 y | Colon (Col) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 5 Months | 3x3x1.4 cm |
| 1 | B6 | Human | M | 28 y | Colon (Col) | Normal | Benign non-neoplastic | ||||
| 1 | B7 | Human | F | 52 y | Colon (Col) | Adenocarcinoma | Malignant | T3N0M0 | Moderately | 1 Month | 6X4X1.5 cm |
| 1 | B8 | Human | M | 64 y | Colon (Col) | Normal | Benign non-neoplastic | ||||
| 1 | B9 | Human | M | 39 y | Small intestine, Duodenum (SmI) | Adenocarcinoma | Malignant | T1N0M0 | Well | 20 Days | 1x1x0.8 cm |
| 1 | B10 | Human | M | 28 y | Small intestine, Duodenum (SmI) | Normal | Benign non-neoplastic | ||||
| 1 | B11 | Human | M | 72 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T3N1M0 | Poorly | 5 Months | 7x5x5 cm |
| 1 | B12 | Human | M | 20 y | Esophagus (Eso) | Normal | Benign non-neoplastic | ||||
| 1 | C1 | Human | M | 62 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T2N0M0 | Poorly | 20 Days | 3x2.5x1.2 cm |
| 1 | C2 | Human | F | 83 y | Esophagus (Eso) | Normal | Benign non-neoplastic | ||||
| 1 | C3 | Human | M | 50 y | Esophagus (Eso) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 1 Month | 3x2x1.5 cm |
| 1 | C4 | Human | F | 76 y | Esophagus (Eso) | Normal | Benign non-neoplastic | ||||
| 1 | C5 | Human | F | 54 y | Fallopian tube (Fal) | Adenocarcinoma | Malignant | T1N0M0 | Poorly | 1 Month | Diameter 0.8 cm |
| 1 | C6 | Human | F | 47 y | Fallopian tube (Fal) | Normal | Benign non-neoplastic | ||||
| 1 | C7 | Human | M | 74 y | Gallbladder (Gal) | Adenocarcinoma | Malignant | T2N0M0 | Well | 1 Month | 3x2x2.5 cm |
| 1 | C8 | Human | M | 24 y | Gallbladder (Gal) | Normal | Benign non-neoplastic | ||||
| 1 | C9 | Human | M | 59 y | Kidney (Kid) | Renal cell carcinoma | Malignant | T4N0M0 | Well | 1 Month | 13x10x7 cm |
| 1 | C10 | Human | M | 50 y | Kidney (Kid) | Normal | Benign non-neoplastic | ||||
| 1 | C11 | Human | M | 50 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | Moderately | 30 Days | 3.5x3x3 cm |
| 1 | C12 | Human | M | 26 y | Kidney (Kid) | Normal | Benign non-neoplastic | ||||
| 1 | D1 | Human | F | 47 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | Moderately | 1 Year | 4x3 cm |
| 1 | D2 | Human | M | 26 y | Liver (Liv) | Normal | Benign non-neoplastic | ||||
| 1 | D3 | Human | M | 60 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | Moderately | 1 Year | 3.5x3.5x3 cm |
| 1 | D4 | Human | M | 30 y | Liver (Liv) | Normal | Benign non-neoplastic | ||||
| 1 | D5 | Human | F | 65 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T1N0M0 | Poorly | 3 Months | Diameter 2.5 cm |
| 1 | D6 | Human | M | 26 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | D7 | Human | M | 66 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T4N1M1 | Poorly | 5 Months | Diameter 8 cm |
| 1 | D8 | Human | M | 24 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | D9 | Human | M | 70 y | Lung (Lng) | Adenosquamous carcinoma | Malignant | T2N1M0 | Moderately | Diameter 4 cm | |
| 1 | D10 | Human | M | 21 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | D11 | Human | F | 74 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T2N0M0 | Moderately | 1 Month | Diameter 3.5 cm |
| 1 | D12 | Human | F | 83 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | E1 | Human | M | 76 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | T1N0M0 | Well | 2 Weeks | Diameter 0.8 cm |
| 1 | E2 | Human | M | 26 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | E3 | Human | M | 68 y | Lymph node (Lym) | Lymphoma | Malignant | T3N0M0 | Well | 1 Year | 6x5x4 cm |
| 1 | E4 | Human | M | 29 y | Lymph node (Lym) | Normal | Benign non-neoplastic | ||||
| 1 | E5 | Human | M | 76 y | Lymph node (Lym) | B cell lymphoma | Malignant | ||||
| 1 | E6 | Human | F | 61 y | Lymph node (Lym) | Normal | Benign non-neoplastic | ||||
| 1 | E7 | Human | F | 60 y | Ovary (Ova) | Adenocarcinoma | Malignant | T3N3M1 | Poorly | 1 Month | 5x5x4 cm |
| 1 | E8 | Human | F | 50 y | Ovary (Ova) | Normal | Benign non-neoplastic | ||||
| 1 | E9 | Human | F | 34 y | Ovary (Ova) | Cystadenocarcinoma, Mucinous | Malignant | Poorly | 2 Years | 12x11.5x4 cm | |
| 1 | E10 | Human | M | 60 y | Ovary (Ova) | Normal | Benign non-neoplastic | ||||
| 1 | E11 | Human | U | Pancreas (Pnc) | Adenocarcinoma | Malignant | |||||
| 1 | E12 | Human | M | 66 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | ||||
| 1 | F1 | Human | M | 59 y | Parotid gland (Pdg) | Plasmacytoma | Malignant | T2N0M0 | 2 Months | 6x5x4 cm | |
| 1 | F2 | Human | M | 25 y | Parotid gland (Pdg) | Normal | Benign non-neoplastic | ||||
| 1 | F3 | Human | M | 63 y | Prostate (Pst) | Adenocarcinoma, Mucinous | Malignant | ||||
| 1 | F4 | Human | M | 23 y | Prostate (Pst) | Normal | Benign non-neoplastic | ||||
| 1 | F5 | Human | M | 54 y | Rectum (Rec) | Adenocarcinoma, Ulcer | Malignant | T3N0M0 | Moderately | 7 Months | 6x4.5x1 cm |
| 1 | F6 | Human | M | 23 y | Rectum (Rec) | Normal | Benign non-neoplastic | ||||
| 1 | F7 | Human | M | 71 y | Rectum (Rec) | Adenocarcinoma | Malignant | T2N0M0 | Moderately | 20 Days | Diameter 2 cm |
| 1 | F8 | Human | M | 24 y | Rectum (Rec) | Normal | Benign non-neoplastic | ||||
| 1 | F9 | Human | M | 43 y | Skin (Skn) | Melanoma | Tumor | ||||
| 1 | F10 | Human | F | 44 y | Skin (Skn) | Normal | Benign non-neoplastic | ||||
| 1 | F11 | Human | F | 68 y | Small intestine (SmI) | Adenocarcinoma, Ulcer | Malignant | T2N0M0 | Well | 3 Months | 3x4 cm |
| 1 | F12 | Human | M | 36 y | Small intestine (SmI) | Normal | Benign non-neoplastic | ||||
| 1 | G1 | Human | U | Soft tissue (Sft) | Rhabdomyosarcoma | Malignant | |||||
| 1 | G2 | Human | M | 24 y | Skeletal muscle (Skl) | Normal | Benign non-neoplastic | ||||
| 1 | G3 | Human | M | 40 y | Stomach (Sto) | Adenocarcinoma | Malignant | T2N1M0 | Moderately | 2 Months | 3.6x3.5x2 cm |
| 1 | G4 | Human | M | 66 y | Stomach (Sto) | Normal | Benign non-neoplastic | ||||
| 1 | G5 | Human | M | 48 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | Poorly | 1 Month | 6x5x2 cm |
| 1 | G6 | Human | F | 39 y | Stomach (Sto) | Normal | Benign non-neoplastic | ||||
| 1 | G7 | Human | F | 42 y | Stomach (Sto) | Adenocarcinoma | Malignant | T2N1M0 | Moderately | 15 Days | 4.2x4x2.2 cm |
| 1 | G8 | Human | M | 47 y | Stomach (Sto) | Normal | Benign non-neoplastic | ||||
| 1 | G9 | Human | M | 43 y | Testis (Tes) | Seminoma | Tumor | T1NxM0 | 2 Months | 2.5x1.5x1.5 cm | |
| 1 | G10 | Human | M | 27 y | Testis (Tes) | Normal | Benign non-neoplastic | ||||
| 1 | G11 | Human | F | 66 y | Tonsil (Tsl) | Squamous cell carcinoma | Malignant | TxN1M0 | Well | 1 Year | |
| 1 | G12 | Human | M | 76 y | Tonsil (Tsl) | Normal | Benign non-neoplastic | ||||
| 1 | H1 | Human | M | 60 y | Throat, Pharynx (Thr) | Squamous cell carcinoma | Malignant | Moderately | 1 Month | 2.9x2.5x1.2 cm | |
| 1 | H2 | Human | M | 26 y | Throat, Pharynx (Thr) | Normal | Benign non-neoplastic | ||||
| 1 | H3 | Human | F | 43 y | Thymus (Tms) | Thymoma | Tumor | T3N0M0 | Well | 10 Days | 16x10x10 cm |
| 1 | H4 | Human | M | 29 y | Thymus (Tms) | Normal | Benign non-neoplastic | ||||
| 1 | H5 | Human | F | 27 y | Thyroid (Tyd) | Adenocarcinoma, Papillary | Malignant | T1N0M0 | Moderately | 15 Years | 1.7x1.5x1.2 cm |
| 1 | H6 | Human | M | 23 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | ||||
| 1 | H7 | Human | M | 58 y | Thyroid (Tyd) | Adenocarcinoma | Malignant | T3N0M0 | Poorly | 6 Months | 5x4.6x4 cm |
| 1 | H8 | Human | M | 26 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | ||||
| 1 | H9 | Human | F | 49 y | Uterus (Ute) | Leiomyoma | Tumor | Well | 2 Years | ||
| 1 | H10 | Human | M | 8 y | Uterus (Ute) | Normal | Benign non-neoplastic | ||||
| 1 | H11 | Human | F | 62 y | Uterus (Ute) | Adenocarcinoma | Malignant | T1N0M0 | Poorly | 2 Months | Diameter 0.1 cm |
| 1 | H12 | Human | F | 40 y | Uterus (Ute) | Normal | Benign non-neoplastic |